Riskpilot← Back to searchSign inGet full accessAngerud consulting AB
ABActiveOrg 5568419278Västra Parkgatan 12General medical practice activities · NACE 8621Est. 20111 employees
Revenue 2024
SEK 2,1M
-35% vs 2023
EBITDA margin
17.6%
-74% vs 2023
Equity ratio
22.5%
Financial strength
Net profit 2024
SEK 189K
+774% vs 2023
| Revenue | SEK 2,1M | -35% |
| EBITDA | SEK 364K | -74% |
| Net profit | SEK 189K | +774% |
| Total assets | SEK 2,7M | -22% |
| Equity | SEK 597K | -2% |
| Employees | 1 | — |
Legal name
Angerud consulting AB
Org number
5568419278
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
14 februari 2011
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva läkarkonsultverksamhet, utbildnings- produktion, utbildning, medicinsk testverksamhet och därmed förenlig verksamhet.
Address
Västra Parkgatan 12
Email
matsangerud@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 305 | 3 063 | 3 209 | 3 163 | 2 065 |
| Staff expenses | — | — | — | — | −1 590 |
| EBITDA | 659 | 339 | 720 | 1 409 | 364 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | 659 | 339 | 720 | 1 409 | 364 |
| Net financials | −7 | −7 | −12 | −2 274 | −92 |
| Profit before tax | 486 | 492 | 645 | 264 | 268 |
| Tax | −106 | −104 | −139 | −292 | −80 |
| Net profit | 380 | 388 | 506 | −28 | 189 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 602 | 3 321 | 3 660 | 3 397 | 2 652 |
| Equity | 843 | 831 | 937 | 609 | 597 |
| Long-term debt | 1 675 | 1 564 | 1 442 | 1 432 | 955 |
| Short-term debt | 472 | 473 | 766 | 842 | 581 |
| Total debt | 2 147 | 2 037 | 2 208 | 2 274 | 1 535 |
EBITDA margin
17.6%
This company
15.8%
Market median
+11% vs market
20202024
Equity ratio
22.5%
This company
38.2%
Market median
-41% vs market
20202024
Return on equity
31.6%
This company
18.4%
Market median
+72% vs market
20202024
Net profit margin
9.1%
This company
8.1%
Market median
+12% vs market
20202024
Asset turnover
0.78×
This company
1.12×
Market median
-30% vs market
20202024
Debt / equity
3.44×
This company
0.62×
Market median
-455% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
AI Chief Executive Officer | Chief Executive Officer | 2020 |
PT Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Chairman | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Angerud consulting AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Ingeborg Angerud | Chief Executive Officer | 0 companies |
| Pär Tobias Thorsson | Audit | 0 companies |
| Tilda Anna Maria Angerud | Board of Directors | 0 companies |
| Mats Roger Angerud | Chairman | 0 companies |
| Gudrun Maria Angerud | Board of Directors | 0 companies |